Provided by Tiger Trade Technology Pte. Ltd.

ResMed

219.95
-1.1000-0.50%
Pre-market: 219.950.00000.00%07:37 EDT
Volume:1.20M
Turnover:263.31M
Market Cap:31.73B
PE:21.09
High:220.85
Open:220.85
Low:217.00
Close:221.05
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:0.93
T/O Rate:0.84%
Dividend:2.40
Dividend Rate:1.09%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:4.82
PE(LYR):21.09

Loading ...

Resmed - Enters Accelerated Share Repurchase Agreement to Repurchase $450 Mln of Common Stock - SEC Filing

THOMSON REUTERS
·
Sep 02

Resmed - Final Settlement of Asr Agreement Scheduled for December 2026 - SEC Filing

THOMSON REUTERS
·
Sep 02

Resmed Inc Stock (RMD) Moved Down by 3.25% on Sep 1: Facts Behind the Movement

TradingKey
·
Sep 02

ResMed completes divestment of MatrixCare to Frazier Healthcare Partners

TIPRANKS
·
Sep 01

ResMed Price Target Raised to $267.00/Share from $255.00 by Keybanc

Dow Jones
·
Aug 31

KeyBanc Adjusts Price Target on ResMed to $267 From $255, Keeps Overweight Rating

MT Newswires Live
·
Aug 31

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 29

Lr 1.15.3 Compliance-Rmd.n

Reuters
·
Aug 28

ResMed CEO Farrell, CFO Bloomer to Present at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 28

ResMed Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Aug 26

ResMed Tests Wearable PAP Device, Signaling Next Wave of Sleep Apnea Innovation

TIPRANKS
·
Aug 26

23Xi Racing Nascar Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams up with Resmed to Help Others Recognize the Signs

THOMSON REUTERS
·
Aug 25

ResMed Updates FX Rate and Tax Details for ASX CDI Dividend

TIPRANKS
·
Aug 24

Update - Dividend/Distribution - RMD-RMD.N

Reuters
·
Aug 24

ResMed Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 22

ResMed Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 20

ResMed’s New OSA Diagnostic Study Signals Next Wave in Home Sleep Testing

TIPRANKS
·
Aug 20

Resmed Inc Stock (RMD) Moved Up by 3.43% on Aug 19: What Investors Need To Know

TradingKey
·
Aug 20

ResMed Initiated at Neutral by Rothschild & Co

Dow Jones
·
Aug 19

Rothschild & Co Redburn Initiates ResMed at Neutral With $230 Price Target

MT Newswires Live
·
Aug 19